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Introduction {#sec005}
============

Free-living amoebae (FLA) are unicellular eukaryotic organisms that can grow independently in different environments, including natural and man-made bodies of water; lakes, ponds, swimming pools, and even treated water supplies \[[@pone.0229681.ref001]--[@pone.0229681.ref003]\]. Some genera of FLA such as *Acanthamoeba*, *Vahlkampfia*, *Naegleria and Hartmannella* are opportunistically pathogenic to humans \[[@pone.0229681.ref001], [@pone.0229681.ref004]\].

The term *Acanthamoeba* keratitis (AK) refers to infection of the cornea by *Acanthamoeba*. However, other FLA such as *Vahlkampfia* and *Hartmannella* are also known causative agents of keratitis \[[@pone.0229681.ref004], [@pone.0229681.ref005]\]. AK and other amoebal keratitis are increasingly being recognized as a severe ocular infection worldwide that occurs most often among contact lens (CL) wearers and can lead to blindness \[[@pone.0229681.ref006]--[@pone.0229681.ref010]\]. Water contamination has been recognized as the most important risk factor for CL-associated AK \[[@pone.0229681.ref011]--[@pone.0229681.ref014]\].

*Acanthamoeba* keratitis was first reported in 1974 as an extremely rare disease \[[@pone.0229681.ref015]\]. With the increased population of CL wearers, the incidence of AK has significantly risen \[[@pone.0229681.ref016], [@pone.0229681.ref017]\]. The reported incidence of AK in developed countries is up to 149 cases per million per year for contact lens wearers but it is less than 2 per million per year for non-contact lens wearers \[[@pone.0229681.ref018], [@pone.0229681.ref019]\]. In an outbreak in England and Wales during 1997--1999, the annual incidence of AK was 1.13 (in general adults) to 21.14 per million (in CL wearers) \[[@pone.0229681.ref018]\]. The latter study also found that the incidence of AK was much greater in areas supplied with hard water, which enhances limescale formation on pipes and so increases colonisation of *Acanthamoeba* \[[@pone.0229681.ref018]\]. Furthermore, distance from water purification plants, use of stagnant water (for example cisterns), and warmer air temperature were found can be associated with higher incidence of AK \[[@pone.0229681.ref014], [@pone.0229681.ref019]--[@pone.0229681.ref026]\]. In a more recent outbreak that started in the UK in 2010--2011 a three-fold increase in the incidence of AK was reported compared to the outbreak in 2004--2009 \[[@pone.0229681.ref027]\]. The increased number of AK cases in the UK has been linked to increased use of disposable contact lenses in case control studies \[[@pone.0229681.ref028], [@pone.0229681.ref029]\] and improper lens hygiene \[[@pone.0229681.ref029]\].

Kilvington *et al*. have found 89% of patients with culture-positive AK contained FLA including *Acanthamoeba* in tap water from their kitchens, or bathrooms, and water storage tanks were implicated as promoting this colonisation \[[@pone.0229681.ref011]\]. *Acanthamoeba* were cultured from 30% of all homes, and 75% of isolates from domestic water and isolates from the corneas of AK patients had identical mtDNA profiles \[[@pone.0229681.ref011]\]. However, that study did not examine water samples from CL wearers who were not AK patients. Such sampling may help the understanding of the CL-wearing population's risk of developing AK. In the current study, samples from both AK patients and control CL wearers and from different areas of their kitchen and bathroom sinks were cultured to understand whether AK patients have higher rates of *Acanthamoeba* sink colonisation than control CL wearers. The current study also aimed to determine the differences in the prevalence of *Acanthamoeba* and FLA in spouts, overflows and drains of kitchens and bathrooms, whether *Acanthamoeba* colonisation of domestic water systems remained constant over time and whether domestic waterborne *Acanthamoeba* isolates were similar to those isolated from cases of AK.

Methods {#sec006}
=======

Sample collection {#sec007}
-----------------

A total of 129 AK patients from Moorfield's Eye Hospital, London and 64 control CL wearers from Institute of Optometry, London were included in this study. The research protocol received approval from the National Research Ethics Service Committee London-Hampstead (REC reference 13/LO/0032) and the Moorfields Eye Hospital Research governance committee. Written informed consent was received from participants before initiation of the study. Each participant was provided with a sampling pack containing six sterile polyester-tipped applicators and sterile screw-cap test tubes, written instructions (Supplementary information [S1 Data](#pone.0229681.s001){ref-type="supplementary-material"}) and a questionnaire which included questions on the suburb, date and time of sample collection, and the date and time that samples were returned to researchers. Participants were requested to swab the inside of their bathroom and kitchen spouts, sink drains and overflows for 10 seconds with the applicator, place the swab into the test tube, fill the tube with 5mL cold tap-water, then fasten the test tube cap tightly. A total of 23 repeat samples at least one month apart were collected from patient's kitchen and bathroom.

Culture and microscopy {#sec008}
----------------------

Upon receipt at the laboratory, tubes were vortexed and 500 μL of water was inoculated onto 1.4% non-nutrient agar (NNA) plate pre-seeded with 100μL of viable *Escherichia coli*. Each agar plate was then incubated at 32°C in sealed polythene bags. After incubation for 3--4 days, plates were examined daily for up to 10 days using an inverted light microscope for the presence of FLA and *Acanthamoeba*. Isolates were identified by morphologic examination of the trophozoite and cyst forms \[[@pone.0229681.ref030]\]. Samples identified with *Acanthamoeba* were classified as *Acanthamoeba* positive and those with *Acanthamoeba* or FLA were classified as FLA in current analysis.

PCR assay, *coxA* sequencing and sequence homology analysis {#sec009}
-----------------------------------------------------------

Nucleotide sequence of the mitochondrial cytochrome oxidase subunit-1 and -2 (*cox1/2*) of corneal isolates were compared with isolates from the patients' homes. DNA was extracted using Chelex resin (MB Chelex-100 resin; Bio-Rad Laboratories, Hercules, CA, USA) following the method described by Kilvington *et al*.\[[@pone.0229681.ref031]\]. *Cox1/2* was amplified by PCR using previously established primer and cycle conditions \[[@pone.0229681.ref011]\]. The amplified products were sent for Sanger sequencing and DNA sequences were aligned using ClustalW and a phylogenetic tree constructed using MEGA 7 \[[@pone.0229681.ref032]\].

Statistical analysis {#sec010}
--------------------

The Pearson Chi-square test was used to assess whether there was a statistically significant difference in the association between sampling sites. Odds ratios and their 95% confidence intervals (95% CIs) were calculated to measure association between AK cases and detection rate of *Acanthamoeba* and FLA in AK patients' and CL controls' homes.

Results {#sec011}
=======

*Acanthamoeba* and free living amoeba colonisation {#sec012}
--------------------------------------------------

A total of 513 samples from 77 AK patients and 189 samples from 40 CL controls were retrieved and examined in this study. Samples were collected from water tap-spouts, sink overflows and drains from the kitchen and bathroom. The proportion of samples from kitchens and bathrooms were broadly similar ([Fig 1](#pone.0229681.g001){ref-type="fig"}). Samples collected from the cloakrooms of AK patients were excluded from the current analysis because the number of samples were small (1.7%) and there were no cloakrooms samples from CL controls group.

![Distribution of samples analysed in current study.](pone.0229681.g001){#pone.0229681.g001}

A slightly higher proportion of *Acanthamoeba* were cultured from bathrooms (average 21.5%) compared to kitchens (average16.9%) ([Fig 2](#pone.0229681.g002){ref-type="fig"}) and there was no difference in this proportion between the patient and control group. However, bathrooms yielded a higher proportion of FLA positive samples compared to kitchens. Bathrooms from the AK cohort had a higher proportion (72.1%) of FLA than samples from the control's bathrooms (54.3%) (p\<0.05) (OR 2.1; 95% CI 1.33--3.55). Furthermore, AK patient's bathrooms had a significantly higher proportion of FLA than kitchens (p\<0.05) ([Fig 2](#pone.0229681.g002){ref-type="fig"}). Controls had a similar higher proportion of FLA from bathrooms, but this did not reach statistical significance.

![Overall colonisation of *Acanthamoeba* and free-living amoeba (FLA) in samples from bathroom and kitchen in patients and control groups.\
\* denotes level of significance (\*p ≤ 0.05, \*\*p ≤ 0.01, \*\*\*p ≤ 0.001, \*\*\*\*p≤ 0.0001).](pone.0229681.g002){#pone.0229681.g002}

Colonisation of *Acanthamoeba* in tap-spouts was lower in both bathrooms and kitchens (p\<0.05) than drains or overflows, but there was no statistical difference between patients and controls in the prevalence of *Acanthamoeba* in these sites ([Fig 3](#pone.0229681.g003){ref-type="fig"}). On the other hand, the rate of colonisation of FLA was higher in drains, overflows and tap-spouts of patients' kitchens and bathrooms compared to these three sites from controls, and this reached statistical significance between bathroom's overflow (controls 14/27 vs patients, 55/72, p = 0.02) and kitchen's drain (controls 8/25 vs patients 40/66, p = 0.02) ([Fig 4](#pone.0229681.g004){ref-type="fig"}).

![Colonisation of *Acanthamoeba* in samples for spout, drain and overflow from bathroom and kitchen in patients and control groups.](pone.0229681.g003){#pone.0229681.g003}

![Colonisation of free-living amoeba (FLA) in samples for spout, drain and overflow from bathroom and kitchen in patients and control groups.\
\* denotes level of significance (\*p ≤ 0.05, \*\*p ≤ 0.01, \*\*\*p ≤ 0.001, \*\*\*\*p≤ 0.0001).](pone.0229681.g004){#pone.0229681.g004}

Twenty-three repeat samples at the two-sampling time-points for both bathrooms and kitchens spouts were examined to understand whether *Acanthamoeba* was consistently present at the same sites. *Acanthamoeba* isolation appeared to be sporadic from either bathrooms or kitchens ([Table 1](#pone.0229681.t001){ref-type="table"}).

10.1371/journal.pone.0229681.t001

###### Repeatability of samples.

![](pone.0229681.t001){#pone.0229681.t001g}

  Bathroom             Kitchen                                                        
  -------------------- ---------- ---- ---------- -------------------- ---------- --- ---
  **Second samples**   Positive   1    2          **Second samples**   Positive   0   3
  Negative             3          17   Negative   3                    17             

Patients and environmental *Acanthamoeba* colonisation {#sec013}
------------------------------------------------------

Four AK patients were selected to the study genetic relatedness between pathogenic and environmental isolates on the basis of association between case and detection of *Acanthamoeba* in water samples from their homes. Partial sequence of the mitochondrial cytochrome oxidase gene (*coxA 1/2*) was obtained from *Acanthamoeba* isolates of four different keratitis patients and those sequences were compared with isolates from the patient's home. [Fig 5](#pone.0229681.g005){ref-type="fig"} shows that each pathogenic isolate had the identical *coxA 1/2* sequence to at least one domestic water isolate including isolates from both the kitchen and the bathroom. The *Acanthamoeba* isolate from patient ID78 was similar to isolates from the patient's bathroom spout, drain and overflow and their kitchen's overflow suggesting a possible source of keratitis isolate. This isolate was also similar to the corneal isolate from another patient ID47 and an isolate from that patient's kitchen spout, suggesting possibility of common source of infections. For patients ID81 and ID37, their corneal isolates were similar to those from their bathrooms. Water contact was reported by three of these four patients in the days prior to suffering AK.

![Cytochrome oxidase gene (*coxA 1/2*) sequence comparison of patient and environmental *Acanthamoeba* isolates.](pone.0229681.g005){#pone.0229681.g005}

Discussion {#sec014}
==========

Domestic tap water is a major risk factor for contact-lens associated *Acanthamoeba* keratitis \[[@pone.0229681.ref011], [@pone.0229681.ref018], [@pone.0229681.ref020]\] and is a reservoir for *Acanthamoeba* and other FLA \[[@pone.0229681.ref011]\]. Based on *coxA 1/2* gene sequence \[[@pone.0229681.ref033]\], this study identified that isolates from water sources were very similar to isolates from the corneas of AK patients, suggesting that domestic waterborne *Acanthamoeba* could be associated with AK. The current study examined water samples from CL wearers who were not AK patients and compared these to samples from AK patients. There was no variation in the rate of colonisation of *Acanthamoeba* in kitchens and bathrooms of AK patients compared to that of CL wearers controls, suggesting that all contact lens wearers are at risk of developing AK and it is not that AK patients have bathrooms or kitchens that are more frequently colonised. Patient's bathrooms yielded a higher proportion of FLA compared to the bathrooms of control CL wearers or the kitchens of patients. Poorly maintained sinks may allow microbial biofilms to form, and this is believed to facilitate amoebal colonisation of water outlets and drains \[[@pone.0229681.ref011]\], not least because amoebae can graze of the bacteria in biofilms \[[@pone.0229681.ref034]\].

The prevalence of *Acanthamoeba* observed in this study (21.5%) was slightly lower than the prevalence reported by another UK based study, in which Kilvington *et al*. isolated *Acanthamoeba* from 30% of homes \[[@pone.0229681.ref011]\]. In the current study tap spouts tended to have filters on them making it difficult to swab the inside of spouts and this could be the reason for these differences \[[@pone.0229681.ref011]\]. In addition, spouts have the fastest water flow and large volume of water regularly flows through it, which self-flushes the spouts and may prevent colonisation of FLA. Furthermore, there is a wide variation in the rate of isolation of *Acanthamoeba* in previous reports. Studies based in Hong Kong have shown that household tap water yielded 10% \[[@pone.0229681.ref035]\], 8.3% \[[@pone.0229681.ref036]\] and 7.7% \[[@pone.0229681.ref036]\] *Acanthamoeba* positive samples. In addition, studies from Scotland (12% bathrooms, 2% kitchen) \[[@pone.0229681.ref037]\], Jamaica (36%, tap-water) \[[@pone.0229681.ref038]\] and Florida (2.8%, domestic water) \[[@pone.0229681.ref039]\] have reported various isolation rates in water samples. One of the reasons for these variations may be due to use of different methods for identification of *Acanthamoeba*, for example morphological \[[@pone.0229681.ref039]\] versus molecular \[[@pone.0229681.ref038]\] techniques. Given that PCR-based methods are more sensitive than culture for detection of *Acanthamoeba* \[[@pone.0229681.ref040]\], further studies based on molecular identification will be required to validate rate of isolation of *Acanthamoeba* observed in the current study.

The domestic water supply system of the UK, which uses water storage cisterns as well as often having hard water, is believed to be a cause for the higher prevalence of *Acanthamoeba* in the tap water in this region \[[@pone.0229681.ref011]\]. *Acanthamoeba* and other microbes proliferate in the cistern water. Also, there is a seasonal trend with the colonisation of *Acanthamoeba* increasing in warmer months \[[@pone.0229681.ref022]--[@pone.0229681.ref024]\].

A limitation of this study is that the genus-level identification of FLA by molecular methods was not performed. FLA such as *Hartmannella* and *Vahlkampfiid* amoebae \[[@pone.0229681.ref004], [@pone.0229681.ref005]\], although rare compared to *Acanthamoeba*, are also causative agents of keratitis. In addition, the significantly higher FLA positive samples in the patient cohort suggests that their identification in the genus-level will help to better understand the risk of keratitis associated with domestic tap water. Further studies regarding the pathogenicity of FLA and *Acanthamoeba* will also require assessing the source of transmission as well as the severity of AK.

In conclusion, this study suggested that *Acanthamoeba* colonisation in UK water supply is high and occurs in CL-wearers and AK patients. Domestic water isolates were similar to isolates from the cornea of AK patient, confirming that domestic waterborne *Acanthamoeba* is still associated with keratitis. Advice about avoiding domestic water contact when using CL's should be mandatory.

Supporting information {#sec015}
======================

###### Water sample instruction.

(DOCX)

###### 

Click here for additional data file.
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Major changes

• As your study was designed to search for Acanthamoeba and then record the presence of other FLA I would switch this throughout the text. "To determine whether Acanthamoeba keratitis (AK) patients have higher rates of Acanthamoeba or other free-living amoeba (FLA) colonising domestic sinks than control contact lens (CL) wearers, and whether these isolates are genetically similar to the corneal isolates identified from their CL associated AK."

Answer: The sentence has been modified as suggested.

• There is no description of the other FLA identified, can you describe which others were investigated and found?

o Can this also be broken down within the bar graphs?

Answer: Classification of FLA were not attempted in this study and this was mentioned as a limitation of the study.

"A limitation of this study is that the genus-level identification of FLA by molecular methods was not performed. FLA such as Hartmannella and Vahlkampfiid amoebae \[4, 5\], although rare compared to Acanthamoeba, are also causative agents of keratitis. In addition, the significantly higher FLA positive samples in the patient cohort suggests that their identification in the genus-level will help to better understand the risk of keratitis associated with domestic tap water. Further studies regarding the pathogenicity of FLA and Acanthamoeba will also require assessing the source of transmission as well as the severity of AK"

• The quality of all of the figures need to be improved (use graph pad prism or another software for better images).

Answer: Figures have been reformatted as suggested

Figure 1.

• Do these graphs describe the full picture? Although the graphs tell the reader total numbers it doesn't break down the exact number of samples obtained from the spout from the kitchen of an AK wearer or the drain from the bathroom of a CL control as examples. A reorganization and coloration to be more descriptive may be useful.

Answer: Figures have been reformatted to keep numbers of samples.

Figure 2.

• As you are specifically identifying different FLA, this graph could be a stacked bar graph with different colors representing the different genus of FLA found for both groups and areas swabbed.

Answer: Figures have been reformatted as suggested

As mentioned above genus level identification for FLA was not attempted.

Minor Changes

• Lines 19-21, 37-41, 79, 113 -- switch Acanthamoeba and FLA order.

Answer: The order has been corrected as suggested throughout the manuscript.

• Don't you think using E. coli and 32°C selects for Acanthamoeba over other FLA?

Answer: FLA could be thermophilic (Hartmannella vermiformis and Naegleria) as indicated in this paper <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3469187/>. Data of the current study showed that rate of isolation of FLA was higher than that of Acanthamoeba. Therefore, we believed that the incubation condition does not select one over the other.

• There was no discussion to where the patients were from within the UK (distribution, were these all local to a particular area? -- This data should be easily accessible since collected during the questionnaire). Can you make a conclusion about geographic location, potential differences in water storage methods, sources that the water was from or treatment methods? You may find that there was a particular area that could have an increased risk or contamination. This could be useful for water regulatory and treatment of such bodies of water.

Answer: Yes, we agree that this information would be useful in many ways. However, we were able to collect this information from less than 1/4 of case and controls. Therefore, this analysis has not been added in the manuscript.

• Why were only 4 patients out of 129 compared for Ac coxA? Please discuss.

Answer: Due to time frame of the project, resources and funding availability, we have selected samples from only four patients for genetic characterization. These four patients appeared to have striking association with detection of Acanthamoeba in water sample from their homes. Our aim was to show relatedness between pathogenic and environmental isolates. We have clarified this in manuscript as

Four AK patients were selected to the study genetic relatedness between pathogenic and environmental isolates on the basis of association between case and detection of Acanthamoeba in water samples from their homes. Partial sequence of the mitochondrial cytochrome oxidase gene (coxA 1/2) was obtained from Acanthamoeba isolates of four different keratitis patients and those sequences were compared with isolates from the patient's home.

Lines 24-26 -- "The samples were cultured by inoculating onto a non-nutrient agar plate seeded with Escherichia coli and the plates were incubated at 32˚C and examined for amoebae by microscopy for up to 2 weeks." Could read as "The samples were cultured by inoculating onto a non-nutrient agar plate seeded with Escherichia coli, incubated at 32˚C and examined for amoebae by microscopy for up to 2 weeks."

Answer: The sentence has been corrected as suggested

• Lines 30-36 -- Please add the %'s for spouts, drains, overflow in kitchens and bathrooms.

Answer: Percentage for sampling sites have been added

"Spouts (kitchen 6.7%, bathroom 11%) had the lowest rate of Acanthamoeba isolation compared to drains (kitchen 18.2%, bathroom 27.9%) and overflow (kitchen 39.1%, bathroom 25.9%) either in kitchens or bathrooms (p\<0.05). There was no statistically significant difference between the prevalence of Acanthamoeba in all three sample sites in kitchens (16.9%) compared to all three sample sites in bathrooms (21.5%) and no association for Acanthamoeba prevalence between AK patients and CL controls."

• Line 36 -- Was this the kitchen or bathroom sink?

Answer: It was from both the kitchen and the bathroom. The sentence has been modified as

"All four corneal isolates had the same coxA sequence as at least one domestic water isolate from the patients' sink of the kitchen and the bathroom."

• Line 46 -- Change "potentially" to opportunistically. Where these the different types of FLA identified within this study? Please make reference to which ones?

Answer: This has been changed as suggested.

• Line 71 -- Reference to ref 11 not needed here since it is referenced at the end of the sentence.

Answer: The reference has been deleted.

• Line 95-96 -- If 23x repeat samples were taken from 129 patients from 6 locations within the home there would be 17,802 samples? I would remove this sentence. Or please show the succession of each patient over the 23 month period as a supplemental figure.

Answer: The sentence has been rewritten to avoid this confusion.

"A total of 23 repeat samples at least one month apart were collected from patient's kitchen and bathroom"

• Line 114 -- 513 total samples were obtained from AK patients = 6.6 samples per patient? 189 samples from 40 CL controls = 4.7 samples per patient?

Answer: As mentioned in methods, each patient was provided with six sample collecting pack. However, some of them had not returned all six tubes with sample plus we collected 23 repeat samples from AK patents. This is the reason; the sample numbers are not exact multiple of patient number. To avoid any confusion, the sentence has been modified as

"A total of 513 samples from 77 AK patients and 189 samples from 40 CL controls were retrieved and examined in this study."

Furthermore, the distribution of sample in figure 1 shows that proportion of samples collected from different sites are different.

Figure 1.

• Please add in total numbers for each of the described %'s within the pie chart.

Answer: This has been updated in figure 1.

• Please add discussion about why the 1.17% (6 cases) from the Cloakroom of AK patients was removed.

Answer: This has been added as

"Samples collected from the cloakrooms of AK patients were excluded from the current analysis because the number of samples were small (1.7%) and there were no cloakrooms samples from CL controls group."

• Line 121 -- (The Acanthamoeba comparison should be Figure 2 not "Fig 1". Also spell out figure to keep consistent throughout the MS.

Answer: Corrections made as suggested.

• Line 123-124 -- Do both groups (AK patients and CL control) FLA total include the Acanthamoeba data as well? If so, shouldn't this be removed/normalized?

Answer: In the current analysis, FLA group includes Acanthamoeba or FLA. The rate of presence of Acanthamoeba and FLA was analysed separately for each sampled area. Therefore, there were no duplicate isolates in the analysis. To clarify this, following modifications have been added

"Samples identified with Acanthamoeba were classified as Acanthamoeba positive and those with Acanthamoeba or FLA were classified as FLA in the current analysis."

Figure 2.

• Please shorten the significance bar for the \*\* between the FLA found in patients and controls.

Answer: Figure has been reformatted as suggested

• Please keep consistency between titles of groups for all figures, "AK patients" and "CL controls".

Answer: Corrections have been made throughout

• Line 131-137 -- Please include the \* for level of significance.

Answer: Correction has been made

• Line 133-137 -- Please spell out figure to keep consistency throughout the MS.

Answer: Corrections have been made throughout

• Line 142 -- Please Italicize Acanthamoeba.

Answer: Corrections have been made throughout

Figure 3&4.

• Please keep consistency between titles of groups for all figures, "AK patients" and "CL controls".

Answer: Corrections have been made throughout

• Please shorten the significance bar and center the \* for kitchen drain and bathroom overflow.

Answer: Figure has been reformatted as suggested

Table 1.

• Please centers align and middle aligns text into the center of all boxes of the table.

Answer: Table has been formatted as suggested.

• References font changes.

Answer: Font has been changed to match with manuscript's font.

Reviewer \# 1

Line 138-139 -- Spouts have the fastest flowing and largest volume of water flowing through it with thousands of gallons per month, this may be the reason why you do not see as much bacteria/Acanthamoeba/FLA in that particular area for Fig 3. Should repeat samples be taken from the drain or overflows from these areas for future studies? Please comment/discuss this finding.

Answer: Discussion has been added (line 191 -194)

In the current study tap spouts tended to have filters on them making it difficult to swab the inside of spouts and this could be the reason for these differences \[11\]. In addition, spouts have the fastest water flow and large volume of water regularly flows through it, which self-flushes the spouts and may prevent colonisation of FLA.

Do you think that paranoia of patients when sampling they didn't want to see Acanthamoeba or FLA within their home that they may have stringently cleaned between sampling?

Answer: While a small number of the first samples changed from positive to negative, a similar amount changed in the other direction in repeat sampling. Therefore, it does not appear that this had an effect.

All figures/graphs are of poor quality please use another software program.

Answer: figures have been modified for better quality.

Were attempts to characterize the species/isolate causing the AK in these 4 patients?

Answer: No, only the coxA gene was sequenced.

Supplemental information is clear for samplers.

Answer: Participants were given a verbal instruction and provided with written instruction.

Molecular characterization of FLA should become mandatory in future studies.

Answer: Yes, Authors agree with this and discus it in the manuscript.

Reviewer \#2:

Overall, it is a very well written case-control study on the association between environmental sources of contamination and Acanthamoeba keratitis in UK.

Answer: Authors like to thank reviewer for taking time to review the manuscript and providing comment on it.

As recommended, please include the statistical analysis used for this study in the manuscript (as it is included only in the abstract). As a suggestion, including the odds ratio of exposure to tap water in the AK patient vs the corresponding ratio for control group, would be really interesting.

Answer: Thank you for suggesting this. Statistical analysis has been added to in the methods of the manuscript as suggested. Odd ratios have been included in results.

"Statistical analysis

The Pearson Chi-square test was used to assess whether there was a statistically significant difference in the association between sampling sites. Odds ratios and their 95% confidence intervals (95% CIs) were calculated to measure association between AK cases and detection rate of Acanthamoeba and FLA in AK patients' and CL controls' homes."

Great job!

10.1371/journal.pone.0229681.r003
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